TECH

72.6700.04%
AH

Alpna Hansraj Seth

Independent Director

Dr. Alpna Hansraj Seth, Ph. D., serves as Director at Keros Therapeutics, Inc. since May 1, 2023. Dr. Seth is an Independent Director at Dr. Reddy's Laboratories Limited since September 19, 2023. Dr. Seth retired in October 2022 as the President and Chief Executive Officer of Nura Bio Inc., where she served for three years. From July 2017 to January 2019, Dr. Seth was the Chief Operating Officer of Vir Biotechnology, Incorporated. Prior to joining Vir, Dr. Seth served in several senior global leadership roles of increasing responsibility at Biogen Incorporated. Most recently, she was Senior Vice President and Global Head of the Biosimilars Business Unit at Biogen Incorporated for which she relocated to Europe in 2014. From 1998 through July 2017, Dr. Seth held a range of general management roles at Biogen spanning drug development, commercialization and international operations, including founding Managing Director of Biogen Idec India and Program Executive for several of Biogen major cross-functional drug development programs and commercial product launches. Dr. Seth currently serves on the Board of Directors of Bio-Techne Corporation. Dr. Seth previously served on the Board of Directors of Seagen Incorporated from 2018 until the company acquisition by Pfizer Incorporated in December 2023. She holds a Ph. D. in Biochemistry and Molecular Biology from University of Massachusetts Medical School and conducted her post-doctoral research at Harvard University in Immunology and Structural Biology, both as a Howard Hughes Medical Institute Fellow. She is also a 2002 graduate of the Advanced Management Program at Harvard Business School.

Positions